THIERRY, Sylvain; BENLEULMI, Mohamed Salah; SINZELLE, Ludivine; THIERRY, Eloise; CALMELS, Christina; CHAIGNEPAIN, Stephane; WAFFO TEGUO, Pierre; MERILLON, Jean-Michel; BUDKE, Brian; PASQUET, Jean-Max; LITVAK, Simon; CIUFFI, Angela; SUNG, Patrick; CONNELL, Philip; HAUBER, Ilona; HAUBER, Joachim; ANDREOLA, Marie-Line; DELELIS, Olivier; PARISSI, Vincent

doi:10.1016/j.chembiol.2015.04.020

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

Langue

Article de revue

Ce document a été publié dans

Chemistry & Biology. 2015, vol. 22, n° 6, p. 712-723

Résumé en anglais

The cellular DNA repair hRAD51 protein has been shown to restrict HIV-1 integration both in vitro and in vivo. To investigate its regulatory functions, we performed a pharmacological analysis of the retroviral integration modulation by hRAD51. We found that, in vitro, chemical activation of hRAD51 stimulates its integration inhibitory properties, whereas inhibition of hRAD51 decreases the integration restriction, indicating that the modulation of HIV-1 integration depends on the hRAD51 recombinase activity. Cellular analyses demonstrated that cells exhibiting high hRAD51 levels prior to de novo infection are more resistant to integration. On the other hand, when hRAD51 was activated during integration, cells were more permissive. Altogether, these data establish the functional link between hRAD51 activity and HIV-1 integration. Our results highlight the multiple and opposite effects of the recombinase during integration and provide new insights into the cellular regulation of HIV-1 replication.< Réduire

Métadonnées

Partager cette publication !

Licence d’utilisation du document

Dual and Opposite Effects of hRAD51 Chemical Modulation on HIV-1 Integration

Langue

Ce document a été publié dans

Résumé en anglais

URI

DOI

Unités de recherche